Get notified when NNOX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Iia Grant Restrictions (new) — Nanox AI received Israeli government grants that impose manufacturing location restrictions, royalty payments, and potential penalties for non-compliance.
- Enforceability of Civil Liabilities (new) — The company is incorporated in Israel and most assets and personnel are outside the U.S., making service of process and enforcement of U.S. judgments difficult.
Nano-X Imaging files to sell up to $100M of ordinary shares from time to time; last price $8.10
Filed June 7, 2024 · ~1 min read
Key Changes
-
high
Nano-X may sell up to $100 million of ordinary shares from time to time through agents under a sales agreement; actual sales may be less.
The Offering verify on EDGAR → -
medium
Net proceeds will fund research and development, manufacturing activities, and general corporate purposes; no dividends are planned.
Use of Proceeds verify on EDGAR → -
medium
The company has broad discretion over use of proceeds and may use them in ways that do not enhance operating results or share price.
Risk Factors verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.
Partner
Trade NNOX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify